Abstract
Chest computed tomography (CT) scanning is one of the most important technologies for COVID-19 diagnosis and disease monitoring, particularly for early detection of coronavirus. Recent advancements in computer vision motivate more concerted efforts in developing AI-driven diagnostic tools to accommodate the enormous demands for the COVID-19 diagnostic tests globally. To help alleviate burdens on medical systems, we develop a lesion-attention deep neural network (LA-DNN) to predict COVID-19 positive or negative with a richly annotated chest CT image dataset. Based on the textual radiological report accompanied with each CT image, we extract two types of important information for the annotations: One is the indicator of a positive or negative case of COVID-19, and the other is the description of five lesions on the CT images associated with the positive cases. The proposed data-efficient LA-DNN model focuses on the primary task of binary classification for COVID-19 diagnosis, while an auxiliary multi-label learning task is implemented simultaneously to draw the model's attention to the five lesions associated with COVID-19. The joint task learning process makes it a highly sample-efficient deep neural network that can learn COVID-19 radiology features more effectively with limited but high-quality, rich-information samples. The experimental results show that the area under the curve (AUC) and sensitivity (recall), precision, and accuracy for COVID-19 diagnosis are 94.0%, 88.8%, 87.9%, and 88.6% respectively, which reach the clinical standards for practical use. A free online system is currently alive for fast diagnosis using CT images at the website https://www.covidct.cn/, and all codes and datasets are freely accessible at our github address.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The research was supported by a grant No. 17307218 for Yin from the Research Grants Council of Hong Kong, and the Fundamental Research Funds for the Central Universities of China No. JK1806002 for Liu.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Our work does not require approval from IRB/oversight body.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The data and computer codes used in this study are publicly available.
https://github.com/UCSD-AI4H/COVID-CT
https://github.com/xiaoxuegao499/LA-DNN-for-COVID-19-diagnosis
